Denver, CO, United States of America

Max Seibold

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Max Seibold: Innovator in Pulmonary Disease Research

Introduction

Max Seibold is a prominent inventor based in Denver, Colorado, known for his significant contributions to the field of pulmonary disease research. With a total of five patents to his name, Seibold has made strides in developing methods and compositions that enhance the diagnosis and treatment of various pulmonary disorders.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders." This invention provides diagnostic and therapeutic targets specifically for fibrotic lung disease. Seibold and his team discovered that a genetic variant in the MUC5B gene is linked to increased expression of the gene, which correlates with a higher risk of developing pulmonary diseases and an improved prognosis for those affected. Another notable patent is "Methods of detecting and treating airway inflammatory diseases," which focuses on innovative methods for identifying, diagnosing, and treating individuals at risk for inflammatory diseases of the airways, particularly those driven by type 2 cytokines.

Career Highlights

Max Seibold is affiliated with National Jewish Health, a leading institution in respiratory health. His work at this esteemed organization has allowed him to focus on critical research that addresses the challenges faced by patients with pulmonary disorders. His dedication to advancing medical knowledge and treatment options has positioned him as a key figure in his field.

Collaborations

Seibold has collaborated with notable colleagues, including David A. Schwartz and Jamie Everman, to further enhance the impact of his research. These collaborations have fostered a dynamic environment for innovation and discovery in pulmonary health.

Conclusion

Max Seibold's contributions to pulmonary disease research through his patents and collaborations highlight his commitment to improving patient outcomes. His work continues to pave the way for advancements in the diagnosis and treatment of respiratory conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…